Showing results (261-270 of 282) with videos related to
Sort By:
Pageof 29
Nature Communications|January 17, 2017
Massively parallel digital transcriptional profiling of single cellsGrace X Y Zheng, Jessica M Terry, Phillip Belgrader, et al.Haematologica|October 20, 2022
Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemiaAlan S Wayne, Van Huynh, Nobuko Hijiya, et al.Cancer Immunology Research|May 17, 2022
Modified Manufacturing Process Modulates CD19CAR T-cell Engraftment Fitness and Leukemia-Free Survival in Pediatric and Young Adult SubjectsFrancesco Ceppi, Ashley L Wilson, Colleen Annesley, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2006
Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresisKouhei Yamashita, Mitchell E Horwitz, Akua Kwatemaa, et al.Lancet (London, England)|October 17, 2014
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trialDaniel W Lee, James N Kochenderfer, Maryalice Stetler-Stevenson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2016
High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in AdultsKathryn G Roberts, Zhaohui Gu, Debbie Payne-Turner, et al.Haematologica|February 3, 2022
Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001)Sarah K Tasian, Lewis B Silverman, James A Whitlock, et al.Journal of the National Cancer Institute|July 4, 2024
Optimizing early phase clinical trial washout periods: a report from the Therapeutic Advances in Childhood Leukemia and Lymphoma consortiumEric S Schafer, Teresa Rushing, Kristine R Crews, et al.Pediatric Blood & Cancer|January 17, 2020
Results from an international phase 2 study of the anti-CD22 immunotoxin moxetumomab pasudotox in relapsed or refractory childhood B-lineage acute lymphoblastic leukemiaNirali N Shah, Deepa Bhojwani, Keith August, et al.JAMA|August 26, 2015
Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid LeukemiaJeffery M Klco, Christopher A Miller, Malachi Griffith, et al.Pageof 29